Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
943,594
-
Share change
-
-897,035
-
Total reported value
-
$139,178,080
-
Put/Call ratio
-
58%
-
Price per share
-
$147.54
-
Number of holders
-
99
-
Value change
-
-$137,964,573
-
Number of buys
-
25
-
Number of sells
-
55
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2018
As of 31 Mar 2018,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
943,594 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BROWN ADVISORY INC, ROYAL BANK OF CANADA, ARS Wealth Advisors, LLC, AMERIPRISE FINANCIAL INC, UBS Group AG, MURPHY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, and RAYMOND JAMES & ASSOCIATES.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.